Gonadorelin Injectable
Gonadorelin 10 mg contains the synthetic decapeptide gonadorelin, which is structurally identical to endogenous gonadotropin-releasing hormone (GnRH). Its amino acid sequence (5-oxoPro-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) enables binding to GnRH receptors on anterior pituitary gonadotroph cells, stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
In medical research, gonadorelin has been studied as a diagnostic agent for hypothalamic-pituitary function and historically as a therapeutic for induction of ovulation in women with hypothalamic amenorrhea (orphan drug Lutrepulse, discontinued). All currently FDA-approved gonadorelin products are labeled for veterinary use only, with explicit warnings stating "Not for use in humans".
In bodybuilding and TRT-adjacent contexts, gonadorelin is referenced as a potential alternative to hCG for maintaining testicular function during testosterone therapy. However, its extremely short half-life (2–20 minutes) compared to hCG (approximately 36 hours) creates a fundamental pharmacological difference that has generated significant community debate. Such use falls outside any approved indication.
Research Properties of Gonadorelin 10 mg
- Synthetic GnRH decapeptide identical to endogenous hormone
- Stimulates pituitary LH and FSH release
- Investigated as diagnostic agent for HPG axis function
- Lyophilized powder format for extended stability
- 10 mg per vial for research applications
GnRH Decapeptide
Gonadorelin is the synthetic form of gonadotropin-releasing hormone (GnRH), a decapeptide synthesized and released from the hypothalamus. It travels via the hypophyseal portal system to the anterior pituitary, where it binds GnRH receptors on gonadotroph cells to stimulate synthesis and secretion of LH and FSH.
The peptide's pharmacokinetic profile is notable for its extremely short half-life. Native GnRH has a plasma half-life of 2–20 minutes due to rapid enzymatic degradation. This short duration creates a critical distinction from hCG, which directly mimics LH at the testicular level with a half-life of approximately 36 hours.
Pulsatile administration is essential for proper HPG axis function. Continuous GnRH receptor stimulation causes desensitization and paradoxical suppression of gonadotropins—the therapeutic mechanism used in GnRH agonist treatments for prostate cancer. This pharmacodynamic property requires careful consideration in any research protocol.
Defining Characteristic
Pulsatile Signaling Requirement
Gonadorelin's physiological action depends on pulsatile administration. Continuous exposure causes pituitary desensitization and gonadotropin suppression, distinguishing it fundamentally from hCG and other long-acting gonadotropin analogues.
Gonadorelin 10 mg vs Other Dragon Pharma Preparations
Dragon Pharma offers several compounds targeting the HPG axis and fertility support. HCG directly mimics LH at testicular receptors with a long half-life, while Gonadorelin acts upstream at the pituitary. HMG 150 IU provides exogenous FSH and LH activity. Kisspeptin acts even further upstream, stimulating GnRH neurons in the hypothalamus. These compounds represent different levels of HPG axis intervention with distinct pharmacological profiles.
Typical Dosage Ranges
No controlled trial supports a specific gonadorelin dose for bodybuilding or post-cycle therapy. Community-reported protocols range from 100–250 mcg administered subcutaneously two to three times per week, with some protocols limiting consecutive daily doses to three days to avoid receptor desensitization. Clinical diagnostic use historically involved single intravenous doses of 80–100 mcg.
| Use Case |
Common Reference Range |
Frequency |
| Clinical diagnostic (historical) |
80–100 mcg |
Single IV dose |
| Community TRT adjunct |
100–200 mcg |
2–3× weekly |
| Community PCT protocol |
100 mcg |
Daily for 3 days, then 2–3× weekly |
Reconstitution & Handling
Gonadorelin 10 mg is supplied as a lyophilized powder requiring reconstitution. Bacteriostatic Water is commonly referenced for reconstituting research peptides. A 10 mg vial reconstituted with 2 mL yields a concentration of 5 mg/mL. Standard sterile technique and peptide handling practices should be observed.
Stacking & Research Considerations
Community protocols reference gonadorelin stacking with HCG for combined pituitary and testicular stimulation, or with Kisspeptin for upstream HPG axis activation. However, the extremely short half-life of gonadorelin compared to hCG creates significant pharmacological challenges, and community consensus increasingly questions whether standard gonadorelin protocols adequately replace hCG function.
Important
Individual Response Varies
The information above is for educational reference and does not constitute medical advice. Gonadorelin has not been evaluated by the FDA for safety or efficacy in humans.
Important Safety Information
Gonadorelin's historical human use was limited to diagnostic testing and ovulation induction under the orphan drug Lutrepulse, which is discontinued. The FDA Orphan Drug Designation database lists marketing approval from 1989 with exclusivity ending in 1996, and PubChem classifies the drug's availability status as "Discontinued". No current human safety data or approved product exists.
Important
Non-Medical Use
Non-medical use of gonadorelin falls outside any approved indication. Veterinary products carry explicit warnings stating "Not for use in humans". Product purity does not establish that non-medical use is safe or appropriate.
Potential Adverse Effects
The primary safety concern with gonadorelin is the risk of pituitary desensitization with continuous or high-frequency administration. This mechanism is exploited therapeutically in prostate cancer treatment using long-acting GnRH agonists to suppress testosterone production. Inappropriate dosing frequency could theoretically produce paradoxical gonadotropin suppression rather than stimulation.
Other potential effects associated with GnRH axis manipulation include changes in LH/FSH pulsatility, testosterone fluctuations, and effects on spermatogenesis. No systematic human safety data from controlled trials is available for non-veterinary use.
Conditions Requiring Medical Evaluation
Individuals with hormone-sensitive conditions, pituitary disorders, or those taking medications affecting the HPG axis should exercise particular caution. No formal contraindication list exists for human use because no current approved human indication exists. Veterinary labels restrict use to licensed veterinarians.
Monitoring Considerations
No standardized monitoring protocol exists for non-veterinary gonadorelin use. Clinical diagnostic protocols historically monitored LH and FSH response after administration. Any research use should consider monitoring gonadotropin levels and HPG axis function, though reference ranges for non-medical contexts are not established.
Product Care
Storage & Handling
Store the lyophilized powder under recommended conditions and protect from conditions that could compromise peptide integrity. Follow standard practices for handling lyophilized peptide products and inspect the vial before reconstitution.
Keep all research peptides and injectable products out of the reach of children.
Further Safety Information
USA Domestic 3–5 business days
International 10–15 business days
Order Processing 24–48 business hours
Tracking Provided after dispatch
Direct Supply
Discreet Delivery & Original Packaging
The outer shipping package remains discreet, with no external product details. Products are supplied through the official Dragon Pharma distribution chain.
What to Expect
- Orders are processed after payment confirmation
- USA Domestic shipping is typically faster when local stock is available
- International orders include tracking, though update frequency may vary by destination
- Multiple warehouses may result in separate shipments when applicable
Authenticity Verification
To verify your Gonadorelin 10 mg product, use the security code on the vial label and cross-check it on the official Dragon Pharma site. Original packaging and batch documentation help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Recommended Conditions
Store the lyophilized powder in a cool, dry place protected from light and moisture. The unopened vial should be kept under conditions that preserve the peptide's structural integrity until reconstitution.
Once reconstituted, Gonadorelin solution should be handled according to standard peptide practices. The reconstituted solution is typically less stable than the lyophilized powder and should be stored refrigerated.
Keep out of reach of children. Follow proper handling practices for research peptides and use appropriate sterile technique during reconstitution.
Quick Reference
Do & Don't
- Do store lyophilized powder cool and dry
- Do protect from light and moisture
- Do inspect vial before reconstitution
- Don't expose to excessive heat
- Don't freeze reconstituted solution
- Don't use if powder appears discolored
What is Gonadorelin 10 mg used for?
Gonadorelin 10 mg is a research peptide supplied as a lyophilized powder. It contains synthetic GnRH, which stimulates pituitary LH and FSH release. All FDA-approved gonadorelin products are veterinary-only, labeled "Not for use in humans".
How often should Gonadorelin 10 mg be administered?
No controlled human trials support a specific gonadorelin dosing protocol. Community protocols reference 100–200 mcg administered 2–3 times weekly, with some limiting consecutive daily doses to 3 days to avoid pituitary desensitization.
Does Gonadorelin 10 mg require PCT?
Gonadorelin is sometimes referenced in post-cycle therapy contexts as a potential alternative to hCG for restoring HPG axis function. However, its extremely short half-life creates significant pharmacological challenges compared to hCG. No controlled studies support gonadorelin PCT protocols.
What does Gonadorelin do?
Gonadorelin binds GnRH receptors on anterior pituitary gonadotroph cells, stimulating synthesis and release of LH and FSH. These gonadotropins then act on the testes to support testosterone production and spermatogenesis. Pulsatile administration is essential for proper physiological function.
How long does Gonadorelin take to work?
Gonadorelin's plasma half-life is only 2–20 minutes, so LH/FSH release occurs rapidly after administration but is short-lived. Clinical diagnostic protocols historically measured LH response within 30–60 minutes after intravenous injection.
Is Gonadorelin the best GnRH analogue?
Gonadorelin is the native GnRH sequence, while longer-acting GnRH agonists (leuprolide, triptorelin) and antagonists (cetrorelix) have been developed for specific clinical applications. No single GnRH analogue is universally superior; selection depends on the research or clinical context.
What is the difference between Gonadorelin and HCG?
Gonadorelin acts upstream at the pituitary to stimulate endogenous LH/FSH release, while HCG directly mimics LH at testicular receptors. Gonadorelin's half-life is 2–20 minutes versus hCG's approximately 36 hours, representing fundamentally different pharmacological profiles.
What is the difference between Gonadorelin and Kisspeptin?
Kisspeptin acts even further upstream, stimulating GnRH neurons in the hypothalamus to release endogenous GnRH. Gonadorelin provides exogenous GnRH directly at the pituitary level. Both target the HPG axis but at different points in the signaling cascade.
Is 10 mg of Gonadorelin a lot?
10 mg is the total labeled content of the Gonadorelin 10 mg vial. Clinical diagnostic doses were 80–100 mcg, and community protocols reference 100–200 mcg per administration. The 10 mg vial is a research presentation allowing multiple doses after reconstitution.
What strength is Gonadorelin 10 mg?
Gonadorelin 10 mg by Dragon Pharma contains 10 mg of Gonadorelin per vial as a lyophilized powder. The vial size is 2 mL. This is a research presentation.
Can Gonadorelin be stacked with other peptides?
Community protocols reference gonadorelin stacking with HCG for combined pituitary and testicular stimulation. However, the short half-life of gonadorelin compared to hCG creates significant dosing coordination challenges, and no controlled studies support these combinations.
No reviews found
Please log in to write Gonadorelin 10 mg review.
